Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3553336rdf:typepubmed:Citationlld:pubmed
pubmed-article:3553336lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:3553336lifeskim:mentionsumls-concept:C0039619lld:lifeskim
pubmed-article:3553336lifeskim:mentionsumls-concept:C1442989lld:lifeskim
pubmed-article:3553336lifeskim:mentionsumls-concept:C0680536lld:lifeskim
pubmed-article:3553336pubmed:issue2lld:pubmed
pubmed-article:3553336pubmed:dateCreated1987-6-2lld:pubmed
pubmed-article:3553336pubmed:abstractTextTetanus toxoid purified by antibody-affinity chromatography, was compared with conventionally purified material in a double-blind trial in 205 healthy blood donors. There was neither any difference in immunogenicity as assessed by enzyme-linked immunoassay nor in side-reactions between the two vaccines. This study confirms that side-reactions to tetanus toxoid are not eliminated by purifying it.lld:pubmed
pubmed-article:3553336pubmed:languageenglld:pubmed
pubmed-article:3553336pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3553336pubmed:citationSubsetIMlld:pubmed
pubmed-article:3553336pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3553336pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3553336pubmed:statusMEDLINElld:pubmed
pubmed-article:3553336pubmed:monthMarlld:pubmed
pubmed-article:3553336pubmed:issn0163-4453lld:pubmed
pubmed-article:3553336pubmed:authorpubmed-author:McClellandD...lld:pubmed
pubmed-article:3553336pubmed:authorpubmed-author:BarclayG RGRlld:pubmed
pubmed-article:3553336pubmed:authorpubmed-author:LeakA MAMlld:pubmed
pubmed-article:3553336pubmed:authorpubmed-author:ShepherdW MWMlld:pubmed
pubmed-article:3553336pubmed:authorpubmed-author:LangfordD TDTlld:pubmed
pubmed-article:3553336pubmed:issnTypePrintlld:pubmed
pubmed-article:3553336pubmed:volume14lld:pubmed
pubmed-article:3553336pubmed:ownerNLMlld:pubmed
pubmed-article:3553336pubmed:authorsCompleteYlld:pubmed
pubmed-article:3553336pubmed:pagination119-24lld:pubmed
pubmed-article:3553336pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:3553336pubmed:meshHeadingpubmed-meshheading:3553336-...lld:pubmed
pubmed-article:3553336pubmed:meshHeadingpubmed-meshheading:3553336-...lld:pubmed
pubmed-article:3553336pubmed:meshHeadingpubmed-meshheading:3553336-...lld:pubmed
pubmed-article:3553336pubmed:meshHeadingpubmed-meshheading:3553336-...lld:pubmed
pubmed-article:3553336pubmed:meshHeadingpubmed-meshheading:3553336-...lld:pubmed
pubmed-article:3553336pubmed:meshHeadingpubmed-meshheading:3553336-...lld:pubmed
pubmed-article:3553336pubmed:meshHeadingpubmed-meshheading:3553336-...lld:pubmed
pubmed-article:3553336pubmed:meshHeadingpubmed-meshheading:3553336-...lld:pubmed
pubmed-article:3553336pubmed:meshHeadingpubmed-meshheading:3553336-...lld:pubmed
pubmed-article:3553336pubmed:meshHeadingpubmed-meshheading:3553336-...lld:pubmed
pubmed-article:3553336pubmed:meshHeadingpubmed-meshheading:3553336-...lld:pubmed
pubmed-article:3553336pubmed:meshHeadingpubmed-meshheading:3553336-...lld:pubmed
pubmed-article:3553336pubmed:year1987lld:pubmed
pubmed-article:3553336pubmed:articleTitleDouble-blind comparative trial of standard (commercial) and antibody-affinity-purified tetanus toxoid vaccines.lld:pubmed
pubmed-article:3553336pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3553336pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:3553336pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:3553336pubmed:publicationTypeControlled Clinical Triallld:pubmed